Trulieve Cannabis

Forecast & Rating7 analysts currently cover Trulieve Cannabis, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.18, about 57.5% upside from the current price of $11.54. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Trulieve Cannabis closely still see room for the stock to rise. Data as of Oct 27, 2026; for reference only and not investment advice.